212 related articles for article (PubMed ID: 23201121)
1. ALIX is a Lys63-specific polyubiquitin binding protein that functions in retrovirus budding.
Dowlatshahi DP; Sandrin V; Vivona S; Shaler TA; Kaiser SE; Melandri F; Sundquist WI; Kopito RR
Dev Cell; 2012 Dec; 23(6):1247-54. PubMed ID: 23201121
[TBL] [Abstract][Full Text] [Related]
2. Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins.
Zhou X; Si J; Corvera J; Gallick GE; Kuang J
Biochem J; 2010 Dec; 432(3):525-34. PubMed ID: 20929444
[TBL] [Abstract][Full Text] [Related]
3. Activation of the retroviral budding factor ALIX.
Zhai Q; Landesman MB; Chung HY; Dierkers A; Jeffries CM; Trewhella J; Hill CP; Sundquist WI
J Virol; 2011 Sep; 85(17):9222-6. PubMed ID: 21715492
[TBL] [Abstract][Full Text] [Related]
4. Structural Insight into the Interaction of Sendai Virus C Protein with Alix To Stimulate Viral Budding.
Oda K; Matoba Y; Sugiyama M; Sakaguchi T
J Virol; 2021 Sep; 95(19):e0081521. PubMed ID: 34287046
[TBL] [Abstract][Full Text] [Related]
5. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding.
Fisher RD; Chung HY; Zhai Q; Robinson H; Sundquist WI; Hill CP
Cell; 2007 Mar; 128(5):841-52. PubMed ID: 17350572
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV.
Zhai Q; Fisher RD; Chung HY; Myszka DG; Sundquist WI; Hill CP
Nat Struct Mol Biol; 2008 Jan; 15(1):43-9. PubMed ID: 18066081
[TBL] [Abstract][Full Text] [Related]
7. Alix-Mediated Rescue of Feline Immunodeficiency Virus Budding Differs from That Observed with Human Immunodeficiency Virus.
Del Vecchio C; Celestino M; Celegato M; Palù G; Parolin C; Bouamr F; Calistri A
J Virol; 2020 May; 94(11):. PubMed ID: 32213612
[TBL] [Abstract][Full Text] [Related]
8. The ESCRT-associated protein Alix recruits the ubiquitin ligase Nedd4-1 to facilitate HIV-1 release through the LYPXnL L domain motif.
Sette P; Jadwin JA; Dussupt V; Bello NF; Bouamr F
J Virol; 2010 Aug; 84(16):8181-92. PubMed ID: 20519395
[TBL] [Abstract][Full Text] [Related]
9. ALIX-CHMP4 interactions in the human ESCRT pathway.
McCullough J; Fisher RD; Whitby FG; Sundquist WI; Hill CP
Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7687-91. PubMed ID: 18511562
[TBL] [Abstract][Full Text] [Related]
10. Structure of the Bro1 domain protein BROX and functional analyses of the ALIX Bro1 domain in HIV-1 budding.
Zhai Q; Landesman MB; Robinson H; Sundquist WI; Hill CP
PLoS One; 2011; 6(12):e27466. PubMed ID: 22162750
[TBL] [Abstract][Full Text] [Related]
11. Structure-based in silico identification of ubiquitin-binding domains provides insights into the ALIX-V:ubiquitin complex and retrovirus budding.
Keren-Kaplan T; Attali I; Estrin M; Kuo LS; Farkash E; Jerabek-Willemsen M; Blutraich N; Artzi S; Peri A; Freed EO; Wolfson HJ; Prag G
EMBO J; 2013 Feb; 32(4):538-51. PubMed ID: 23361315
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for viral late-domain binding to Alix.
Lee S; Joshi A; Nagashima K; Freed EO; Hurley JH
Nat Struct Mol Biol; 2007 Mar; 14(3):194-9. PubMed ID: 17277784
[TBL] [Abstract][Full Text] [Related]
13. A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments.
Pires R; Hartlieb B; Signor L; Schoehn G; Lata S; Roessle M; Moriscot C; Popov S; Hinz A; Jamin M; Boyer V; Sadoul R; Forest E; Svergun DI; Göttlinger HG; Weissenhorn W
Structure; 2009 Jun; 17(6):843-56. PubMed ID: 19523902
[TBL] [Abstract][Full Text] [Related]
14. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site.
Usami Y; Popov S; Göttlinger HG
J Virol; 2007 Jun; 81(12):6614-22. PubMed ID: 17428861
[TBL] [Abstract][Full Text] [Related]
15. Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT-independent manner.
Bardens A; Döring T; Stieler J; Prange R
Cell Microbiol; 2011 Apr; 13(4):602-19. PubMed ID: 21129143
[TBL] [Abstract][Full Text] [Related]
16. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins.
Martin-Serrano J; Yarovoy A; Perez-Caballero D; Bieniasz PD
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12414-9. PubMed ID: 14519844
[TBL] [Abstract][Full Text] [Related]
17. Identification and structural characterization of the ALIX-binding late domains of simian immunodeficiency virus SIVmac239 and SIVagmTan-1.
Zhai Q; Landesman MB; Robinson H; Sundquist WI; Hill CP
J Virol; 2011 Jan; 85(1):632-7. PubMed ID: 20962096
[TBL] [Abstract][Full Text] [Related]
18. An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains.
Munshi UM; Kim J; Nagashima K; Hurley JH; Freed EO
J Biol Chem; 2007 Feb; 282(6):3847-55. PubMed ID: 17158451
[TBL] [Abstract][Full Text] [Related]
19. The yeast Alix homolog Bro1 functions as a ubiquitin receptor for protein sorting into multivesicular endosomes.
Pashkova N; Gakhar L; Winistorfer SC; Sunshine AB; Rich M; Dunham MJ; Yu L; Piper RC
Dev Cell; 2013 Jun; 25(5):520-33. PubMed ID: 23726974
[TBL] [Abstract][Full Text] [Related]
20. Identification of the HIV-1 NC binding interface in Alix Bro1 reveals a role for RNA.
Sette P; Dussupt V; Bouamr F
J Virol; 2012 Nov; 86(21):11608-15. PubMed ID: 22896625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
